Veeva Systems Reports Strong Q2 Earnings and Raises Full-Year Guidance
Veeva Systems reported fiscal 2027 second-quarter revenue of $928 million with non-GAAP operating income reaching $416 million, exceeding the company's guidance. The results were driven by strong performance across its commercial cloud offerings including CRM, content, data products, Crossix, and Ostro. Management raised full-year expectations due to consistent growth in these areas. The CEO highlighted Vault CRM selections from major clients like Eli Lilly, Biogen, and Regeneron as a sign of customer trust and product strength. Veeva also noted potential opportunities to win back customers who initially chose Salesforce but faced implementation challenges. Additionally, the company is focusing on Falcon AI, an emerging growth area with high customer interest aimed at improving efficiency and compliance. Veeva's CFO emphasized that commercial subscription revenue grew approximately 13% year-over-year, driven by broad-based demand rather than a single product line. The company also outlined plans to expand its clinical offerings such as EDC, eCOA, RTSM, Safety, LIMS, and the horizontal CRM initiative Aspen.
Tickers: $BIIB $CRM $LLY $REGN $VEEV
Topics: AI strategy CRM momentum financial performance revenue growth